These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38273306)

  • 1. Are the European reference networks for rare diseases ready to embrace machine learning? A mixed-methods study.
    Iskrov G; Raycheva R; Kostadinov K; Gillner S; Blankart CR; Gross ES; Gumus G; Mitova E; Stefanov S; Stefanov G; Stefanov R
    Orphanet J Rare Dis; 2024 Jan; 19(1):25. PubMed ID: 38273306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tuscany Regional Network for rare diseases: from European Reference Networks' experience to registry based organisation and management model for rare diseases.
    Pieroni F; Marrucci S; Di Pietro L; Berni C; Scaletti C
    Orphanet J Rare Dis; 2023 Oct; 18(1):324. PubMed ID: 37833795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].
    Schulz L; Sebode M; Schramm C; Lohse AW
    Internist (Berl); 2021 Apr; 62(4):441-448. PubMed ID: 33687527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Reference networks for rare diseases: what is the conceptual framework?
    Héon-Klin V
    Orphanet J Rare Dis; 2017 Aug; 12(1):137. PubMed ID: 28784158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
    Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
    Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting social welfare legal needs in end-of-life care: co-creation of a system-wide research partnership.
    Hawkins C; Wheatman A; Black D; Pala A; Fu Y; Robinson T; Ling J; Gorman S; Beardon S; Genn H; Hesselgreaves H
    Health Soc Care Deliv Res; 2024 Sep; ():1-21. PubMed ID: 39283651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Reference Network for Rare Neurological Diseases.
    Reinhard C; Bachoud-Lévi AC; Bäumer T; Bertini E; Brunelle A; Buizer AI; Federico A; Gasser T; Groeschel S; Hermanns S; Klockgether T; Krägeloh-Mann I; Landwehrmeyer GB; Leber I; Macaya A; Mariotti C; Meissner WG; Molnar MJ; Nonnekes J; Ortigoza Escobar JD; Pérez Dueñas B; Renna Linton L; Schöls L; Schuele R; Tijssen MAJ; Vandenberghe R; Volkmer A; Wolf NI; Graessner H
    Front Neurol; 2020; 11():616569. PubMed ID: 33519696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare stakeholders' perceptions and experiences of factors affecting the implementation of critical care telemedicine (CCT): qualitative evidence synthesis.
    Xyrichis A; Iliopoulou K; Mackintosh NJ; Bench S; Terblanche M; Philippou J; Sandall J
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012876. PubMed ID: 33599282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing and boosting communication in the European Reference Network for Rare Neurological Diseases (ERN-RND): the impact of offering free educational webinars.
    Brunelle Praschberger A; Post AEM; Hermanns S; Graessner H
    Orphanet J Rare Dis; 2022 Mar; 17(1):89. PubMed ID: 35236389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals' perspectives on cancer care and artificial intelligence.
    Hesso I; Kayyali R; Dolton DR; Joo K; Zacharias L; Charalambous A; Lavdaniti M; Stalika E; Ajami T; Acampa W; Boban J; Nabhani-Gebara S
    Radiat Oncol; 2023 Oct; 18(1):167. PubMed ID: 37814325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking the eHealth professionals' career pathways: A case of Gulf Cooperation Council countries.
    Zakaria N; Zakaria N; Alnobani O; AlMalki M; El-Hassan O; Alhefzi MI; Househ M; Jamal A
    Int J Med Inform; 2023 Feb; 170():104914. PubMed ID: 36521421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
    Talarico R; Aguilera S; Alexander T; Amoura Z; Andersen J; Arnaud L; Avcin T; Marsal Barril S; Beretta L; Bombardieri S; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Cannizzo S; Cavagna L; Chaigne B; Cornet A; Corti P; Costedoat-Chalumeau N; Dāvidsone Z; Doria A; Fenech C; Ferraris A; Fischer-Betz R; Fonseca JE; Frank C; Gaglioti A; Galetti I; Guimarães V; Hachulla E; Holmner M; Houssiau F; Iaccarino L; Jacobsen S; Limper M; Malfait F; Mariette X; Marinello D; Martin T; Matthews L; Matucci-Cerinic M; Meyer A; Milas-Ahić J; Moinzadeh P; Montecucco C; Mouthon L; Müller-Ladner U; Nagy G; Patarata E; Pileckyte M; Pruunsild C; Rednic S; Romão VC; Schneider M; Scirè CA; Smith V; Sulli A; Tamirou F; Tani C; Taruscio D; Taulaigo AV; Tincani A; Ticciati S; Turchetti G; van Hagen PM; van Laar JM; Viera A; de Vries-Bouwstra JK; Zschocke J; Cutolo M; Mosca M
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):3-11. PubMed ID: 35349419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing rare disease care pathways in the Republic of Ireland: a co-operative model.
    Ward AJ; Murphy D; Marron R; McGrath V; Bolz-Johnson M; Cullen W; Daly A; Hardiman O; Lawlor A; Lynch SA; MacLachlan M; McBrien J; Ni Bhriain S; O'Byrne JJ; O'Connell SM; Turner J; Treacy EP
    Orphanet J Rare Dis; 2022 Apr; 17(1):162. PubMed ID: 35410222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?
    Brasil S; Pascoal C; Francisco R; Dos Reis Ferreira V; Videira PA; Valadão AG
    Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31783696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.